stockrow
Friday 6 November 2026
Export AMGN’s income statement to Excel — free account
Amgen Inc.
AMGN Healthcare Drug Manufacturers General
Amgen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $36.8 billion, up 9.95% from fiscal 2024.
- Revenue
- +8.45%
- EPS
- +19.4%
- Free cash flow
- −0.16%
- Total debt
- −1.06%
Quarter to September 2026, against a year earlier
461.71
1.43
+0.31%
Follow AMGN
Alert me
| Sep '26 | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
8 | 8 | 8 | 7 |
+8 more TTM periods Free account |
| 78.35% | 91.47% | 101.32% | 106.10% | ||
| 10.09% | 9.53% | 8.58% | 8.45% | ||
ROIC |
14.29% | 12.98% | 12.12% | 10.48% | |
Return on Tangible Assets |
46.92% | 48.56% | 52.93% | 67.16% | |
Average Days of Receivables |
97.14 | 97.99 | 89.61 | 95.05 | |
Free Cash Flow per Share |
17.71 | 18.84 | 15.92 | 15.06 | |
Free Cash Flow |
9,581.00 | 10,175.00 | 8,597.00 | 8,100.00 | |
Capital Expenditures |
(2,454.00) | (2,303.00) | (2,159.00) | (1,858.00) | |
| Other line items | |||||
Cash ROIC |
11.75% | 12.26% | 10.94% | 11.19% | |
Accounts Receivable Turnover |
4.13 | 4.03 | 4.31 | 4.50 | |
Accounts Payable Turnover |
0.96 | 3.95 | 4.42 | 5.63 | |
Inventory Turnover |
1.78 | 1.81 | 1.83 | 1.82 | |
Average Days of Payables |
671.79 | 90.05 | 90.69 | 71.77 | |
Days of Inventory on Hand |
206.02 | 195.50 | 191.14 | 188.76 | |
Tax Rate |
(0.15) | (0.15) | (0.14) | (0.14) | |
Research and Development Expense of Revenue |
20.15% | 20.03% | 20.16% | 19.79% | |
Selling, General and Administrative Expense of Revenue |
17.94% | 18.42% | 18.71% | 19.18% | |
Share Based Compensation of Revenue |
1.27% | 1.29% | 1.30% | 1.34% | |
Interest Coverage |
4.78 | 4.28 | 3.93 | 3.30 | |
Operating CF/Net income |
1.28 | 1.43 | 1.38 | 1.29 | |
Depreciation/Fixed assets |
0.00 | 0.59 | 0.64 | 0.80 | |
Capex/Depreciation |
0.00 | (0.45) | (0.41) | (0.29) | |
Revenue per Share |
71.91 | 70.55 | 68.93 | 68.31 | |
Operating CF per Share |
22.25 | 23.11 | 19.92 | 18.51 | |
Capex per Share |
(4.54) | (4.26) | (4.00) | (3.45) | |
Capex to Sales |
0.06 | 0.06 | 0.06 | 0.05 |
Columns are period end dates · fundamentals updated 5 Nov 2026